Approval · Notice of Compliance 6026 · 1997
ACT-HIB: Notice of Compliance 6026
Issued August 20, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6026
- Date
- August 20, 1997
- Company
- Connaught Laboratories Ltd.Toronto, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New site for purification
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACT-HIB | Not yet assigned | — |
Medicinal ingredients
- HAEMOPHILUS INFLUENZAE TYPE B-PRP 10 MCG per DOSE
- TETANUS PROTEIN 20 MCG per DOSE